Implication of the RD(Rio)Mycobacterium tuberculosis sublineage in multidrug resistant tuberculosis in Portugal

Detalhes bibliográficos
Autor(a) principal: David, S
Data de Publicação: 2012
Outros Autores: Duarte, E, Leite, C, Ribeiro, J, Maio, J, Paixão, E, Portugal, C, Sancho, L, Sousa, JG
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.10/683
Resumo: Multidrug and extensively drug resistant Mycobacterium tuberculosis are a threat to tuberculosis control programs. Genotyping methods, such as spoligotyping and MIRU-VNTR typing (Mycobacterial Interspersed Repetitive Units), are useful in monitoring potentially epidemic strains and estimating strain phylogenetic lineages and/or genotypic families. M. tuberculosis Latin American Mediterranean (LAM) family is a major worldwide contributor to tuberculosis (TB). LAM specific molecular markers, Ag85C(103) single nucleotide polymorphism (SNP) and RD(Rio) long-sequence polymorphism (LSP), were used to characterize spoligotype signatures from 859 patient isolates from Portugal. LAM strains were found responsible for 57.7% of all tuberculosis cases. Strains with the RD(Rio) deletion (referred to as RD(Rio)) were estimated to represent 1/3 of all the strains and over 60% of the multidrug resistant (MDR) strains. The major spoligotype signature SIT20 belonging to the LAM1 RD(Rio) sublineage, represented close to 1/5th of all the strains, over 20% of which were MDR. Analysis of published datasets according to stipulated 12loci MIRU-VNTR RD(Rio) signatures revealed that 96.3% (129/134) of MDR and extensively drug resistant (XDR) clusters were RD(Rio). This is the first report associating the LAM RD(Rio) sublineage with MDR. These results are an important contribution to the monitoring of these strains with heightened transmission for future endeavors to arrest MDR-TB and XDR-TB.
id RCAP_ce4d198c9c38b1769c11c63aaa8438f2
oai_identifier_str oai:repositorio.hff.min-saude.pt:10400.10/683
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Implication of the RD(Rio)Mycobacterium tuberculosis sublineage in multidrug resistant tuberculosis in PortugalMycobacterium tuberculosisTuberculoseMultidrug-resistant tuberculosisPortugalMultidrug and extensively drug resistant Mycobacterium tuberculosis are a threat to tuberculosis control programs. Genotyping methods, such as spoligotyping and MIRU-VNTR typing (Mycobacterial Interspersed Repetitive Units), are useful in monitoring potentially epidemic strains and estimating strain phylogenetic lineages and/or genotypic families. M. tuberculosis Latin American Mediterranean (LAM) family is a major worldwide contributor to tuberculosis (TB). LAM specific molecular markers, Ag85C(103) single nucleotide polymorphism (SNP) and RD(Rio) long-sequence polymorphism (LSP), were used to characterize spoligotype signatures from 859 patient isolates from Portugal. LAM strains were found responsible for 57.7% of all tuberculosis cases. Strains with the RD(Rio) deletion (referred to as RD(Rio)) were estimated to represent 1/3 of all the strains and over 60% of the multidrug resistant (MDR) strains. The major spoligotype signature SIT20 belonging to the LAM1 RD(Rio) sublineage, represented close to 1/5th of all the strains, over 20% of which were MDR. Analysis of published datasets according to stipulated 12loci MIRU-VNTR RD(Rio) signatures revealed that 96.3% (129/134) of MDR and extensively drug resistant (XDR) clusters were RD(Rio). This is the first report associating the LAM RD(Rio) sublineage with MDR. These results are an important contribution to the monitoring of these strains with heightened transmission for future endeavors to arrest MDR-TB and XDR-TB.ElsevierRepositório do Hospital Prof. Doutor Fernando FonsecaDavid, SDuarte, ELeite, CRibeiro, JMaio, JPaixão, EPortugal, CSancho, LSousa, JG2012-08-30T09:22:00Z2012-01-01T00:00:00Z2012-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.10/683engInfect Genet Evol. 2012 Oct;12(7):1362-71567-1348metadata only accessinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-09-20T15:51:33Zoai:repositorio.hff.min-saude.pt:10400.10/683Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T15:51:55.051607Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Implication of the RD(Rio)Mycobacterium tuberculosis sublineage in multidrug resistant tuberculosis in Portugal
title Implication of the RD(Rio)Mycobacterium tuberculosis sublineage in multidrug resistant tuberculosis in Portugal
spellingShingle Implication of the RD(Rio)Mycobacterium tuberculosis sublineage in multidrug resistant tuberculosis in Portugal
David, S
Mycobacterium tuberculosis
Tuberculose
Multidrug-resistant tuberculosis
Portugal
title_short Implication of the RD(Rio)Mycobacterium tuberculosis sublineage in multidrug resistant tuberculosis in Portugal
title_full Implication of the RD(Rio)Mycobacterium tuberculosis sublineage in multidrug resistant tuberculosis in Portugal
title_fullStr Implication of the RD(Rio)Mycobacterium tuberculosis sublineage in multidrug resistant tuberculosis in Portugal
title_full_unstemmed Implication of the RD(Rio)Mycobacterium tuberculosis sublineage in multidrug resistant tuberculosis in Portugal
title_sort Implication of the RD(Rio)Mycobacterium tuberculosis sublineage in multidrug resistant tuberculosis in Portugal
author David, S
author_facet David, S
Duarte, E
Leite, C
Ribeiro, J
Maio, J
Paixão, E
Portugal, C
Sancho, L
Sousa, JG
author_role author
author2 Duarte, E
Leite, C
Ribeiro, J
Maio, J
Paixão, E
Portugal, C
Sancho, L
Sousa, JG
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório do Hospital Prof. Doutor Fernando Fonseca
dc.contributor.author.fl_str_mv David, S
Duarte, E
Leite, C
Ribeiro, J
Maio, J
Paixão, E
Portugal, C
Sancho, L
Sousa, JG
dc.subject.por.fl_str_mv Mycobacterium tuberculosis
Tuberculose
Multidrug-resistant tuberculosis
Portugal
topic Mycobacterium tuberculosis
Tuberculose
Multidrug-resistant tuberculosis
Portugal
description Multidrug and extensively drug resistant Mycobacterium tuberculosis are a threat to tuberculosis control programs. Genotyping methods, such as spoligotyping and MIRU-VNTR typing (Mycobacterial Interspersed Repetitive Units), are useful in monitoring potentially epidemic strains and estimating strain phylogenetic lineages and/or genotypic families. M. tuberculosis Latin American Mediterranean (LAM) family is a major worldwide contributor to tuberculosis (TB). LAM specific molecular markers, Ag85C(103) single nucleotide polymorphism (SNP) and RD(Rio) long-sequence polymorphism (LSP), were used to characterize spoligotype signatures from 859 patient isolates from Portugal. LAM strains were found responsible for 57.7% of all tuberculosis cases. Strains with the RD(Rio) deletion (referred to as RD(Rio)) were estimated to represent 1/3 of all the strains and over 60% of the multidrug resistant (MDR) strains. The major spoligotype signature SIT20 belonging to the LAM1 RD(Rio) sublineage, represented close to 1/5th of all the strains, over 20% of which were MDR. Analysis of published datasets according to stipulated 12loci MIRU-VNTR RD(Rio) signatures revealed that 96.3% (129/134) of MDR and extensively drug resistant (XDR) clusters were RD(Rio). This is the first report associating the LAM RD(Rio) sublineage with MDR. These results are an important contribution to the monitoring of these strains with heightened transmission for future endeavors to arrest MDR-TB and XDR-TB.
publishDate 2012
dc.date.none.fl_str_mv 2012-08-30T09:22:00Z
2012-01-01T00:00:00Z
2012-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.10/683
url http://hdl.handle.net/10400.10/683
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Infect Genet Evol. 2012 Oct;12(7):1362-7
1567-1348
dc.rights.driver.fl_str_mv metadata only access
info:eu-repo/semantics/openAccess
rights_invalid_str_mv metadata only access
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130383349972992